Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, July 27, 2026

Snapshot: Jul 27, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Mon, Jul 27, 2026 Divergent High

Tech and small caps collapsed while mega-cap financials rallied, splinters everywhere as healthcare crashed and single stocks swung wildly on mixed earnings and deal news.

55% NASDAQ plunged 2.3% and Russell 2000 held flat in a divergent regime where SPY fell 0.4%, signaling a regime breakdown with tech weakness dominating despite broad small-cap resilience and VIX climbing 9.5% on fear resurgence.
30% Extreme dispersion gripped the market with 50 gainers averaging +23.6% (led by ENTX +94% on biotech fundraising and KIDZ +46% on cash disclosure) clashing against 50 losers averaging -30.3% (BIOT -82%, CISS -76%, MPLT -72% on deal/equity dilution), creating a stock-pickers' battleground where healthcare suffered worst at 33% of declines.
15% Healthcare sector led the damage with 10 names in the loser list, while five debutants (REBN, ASPU, MF, KRSP.WT, VGAS) popped back onto gainers list after long absences, and persistent losers CISS and ZCMD extended three-day streaks on capital raises and strategic missteps.

Healthcare drove 33% of losers 5 names returned after long absences CISS · 3-day losers streak ZCMD · 3-day losers streak REBN — first appearance ASPU — first appearance

Market Regime

Mon, Jul 27, 2026 Risk-Off conf: medium macro · prototype

-25

Headwind −100 … +100 · + tailwind / − headwind

VIX18.7 p86 Drawdown-2.6% Held1d · nascent SinceJul 27

Top drivers: VIX percentile ▼ Small-cap leadership ▼ S&P vs 20d avg ▼

processId: history-market-regime

Market Indexes

Mon, Jul 27, 2026 13

S&P 500

7,413.18

−30.10

-0.40%

Dow Jones

52,210.08

+370.82

+0.72%

NASDAQ Composite

24,932.08

−575.99

-2.26%

NASDAQ 100

28,039.21

−565.02

-1.98%

DJ US Total Market

73,489.55

−224.42

-0.30%

Russell 1000

4,039.56

−13.08

-0.32%

S&P MidCap 400

3,795.78

+51.20

+1.37%

Russell 2000

2,948.04

+5.61

+0.19%

Russell 2500

1,259.41

+8.29

+0.66%

Russell 3000

4,220.37

−12.74

-0.30%

Nasdaq Financial-100

7,426.04

+70.90

+0.96%

NIFTY 50

23,995.95

−191.75

-0.79%

VIX

18.67

+1.62

+9.50%

Biggest Gainers

Mon, Jul 27, 2026 50

ENTX

Entera Bio LtdHealthcare

$3.93+$1.93

+94.1%

NASDAQ · Mkt cap $153 M

Entera Bio announced a $275 million oversubscribed private placement led by existing investor BVF Partners, with proceeds extending cash runway to 2030 and funding Phase 3 studies for EB613, directly catalyzing the 94% single-day surge.

The headline establishes a concrete capital raise with two key elements that justify a large equity move: first, the offering was oversubscribed, indicating strong investor demand and confidence in the company's pipeline; second, the proceeds are explicitly tied to extending cash runway into 2030 and fully funding Phase 3 registrational studies for EB613, a lead program. For a biotech company, elimination of near-term financing risk and visible pathway to a pivotal study completion is a material positive, as it removes bankruptcy risk and demonstrates investor backing of the clinical strategy. The involvement of existing investors suggests continuity and conviction. This is a pure financing event with clear implications for trial execution and shareholder runway, not a clinical or regulatory outcome, but the market's reaction reflects relief on capital adequacy and strategic clarity.

LVWR

Livewire Group IncConsumer Cyclical

$2.47+$1.16

+79.5%

NYSE · Mkt cap $254 M

No news headlines were found in the last 48 hours, so the 79.47% gain cannot be directly attributed to a reported event. The spike likely reflects a technical bounce, short-covering, or a delayed market reaction to an untracked announcement.

The absence of recent Yahoo Finance headlines makes it impossible to pinpoint a specific catalyst for Livewire Group's dramatic rally. A nearly 80% single-day jump in a lower-priced equity (trading near $2.47) is typical of stocks vulnerable to momentum, short-squeeze dynamics, or thin liquidity conditions where small volume shifts create outsized percentage moves. Without access to news from before the 48-hour window, insider filings, or real-time social media discussion, viable hypotheses include a delayed market reaction to an older announcement, short-position covering, technical rebound after oversold conditions, or a rumor circulating in retail trading communities. Given Livewire's small-cap positioning, liquidity constraints could amplify normal trading activity into large percentage swings.

KIDZ

Classover Holdings, Inc. Class B Common StockConsumer Defensive

$0.59+$0.19

+46.0%

FBRX

Forte Biosciences, Inc.Healthcare

$76.52+$21.75

+39.7%

JZXN

Jiuzi Holdings, Inc.Consumer Cyclical

$1.35+$0.37

+34.6%

NASDAQ · Mkt cap $687 K

No news headlines appeared in the last 48 hours, so the 34.58% gain cannot be attributed to a specific reported event; the catalyst remains unknown without additional reporting.

Jiuzi Holdings showed a strong single-day move of 34.58% with no corresponding news coverage in the provided feeds. This disconnect suggests either that the catalyst was a delayed market reaction to older news, a technical bounce in a low-price/low-liquidity stock (where small volume shifts can drive large percentage moves), short-covering activity, or an unannounced corporate event not yet reflected in major news aggregators. Micro-cap stocks trading under $2 are particularly susceptible to outsized moves on modest absolute volume. Without access to intraday volume data, company filings, social media mentions, or earnings dates, it is not possible to determine whether this was driven by fundamentals, technicals, or sentiment.

GMEX

GMEX ROBOTICS CORPORATION Class ATechnology

$1.79+$0.46

+32.4%

NASDAQ · Mkt cap $1.0 M

No news headlines were found in the last 48 hours, so the 32% gain likely reflects either delayed market reaction to an untracked announcement, technical trading in a micro-cap, or retail interest in a penny stock.

The absence of recent news makes it difficult to pinpoint a specific catalyst for GMEX Robotics' 32% jump today. However, several common drivers of large single-day moves in low-priced stocks should be considered. First, robotics and automation sectors have seen periodic waves of retail investor enthusiasm, particularly when broader themes like AI or manufacturing resurgence gain media attention. Second, stocks trading under $2 are highly susceptible to technical factors, short covering, and options expiration effects. Third, the lack of headlines may simply reflect that relevant news was published before the 48-hour window or through channels not captured by standard financial RSS feeds. Without access to the company's filings, press releases, or broker research from today, the specific driver remains unidentifiable. The rank as the 6th biggest gainer suggests this was a coordinated market move rather than a random tick, but that alone does not establish causation.

MGN

Megan Holdings LimitedIndustrials

$0.08+$0.02

+30.0%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours, so the 29.95% gain in MGN stock cannot be directly attributed to a specific company announcement or market event based on available information.

The absence of recent headlines makes it difficult to pinpoint a concrete cause for MGN's strong one-day gain. Penny stocks and micro-cap securities like MGN (trading at $0.08) are often sensitive to technical factors, including short covering, retail trading interest on social media, or delayed news dissemination through major financial news feeds. It is also possible that news broke through channels not captured by the Yahoo Finance RSS feed, or that the stock responded to broader market sentiment, sector rotation, or algorithmic trading. Without corroborating headlines or company announcements, any explanation remains speculative. The high volatility typical of ultra-low-priced stocks means single-day moves of this magnitude can occur on relatively modest dollar volume or non-fundamental drivers.

MTNB

Matinas BioPharma Holdings IncHealthcare

$0.34+$0.09

+29.7%

NYSE · Mkt cap $1.3 M

No news headlines were found in the last 48 hours, so the 29.73% gain likely reflects technical trading, sector momentum, short covering, or a delayed market reaction to an untracked catalyst.

Matinas BioPharma is a small-cap biotech stock with minimal analyst coverage and a market price of $0.34, characteristics typical of microcap stocks prone to volatile moves on limited volume. The absence of any news in the prior 48 hours rules out a direct catalyst like an earnings release, clinical trial result, or FDA action as the documented cause. However, several plausible mechanisms could explain the jump. Biotech stocks often spike on short-squeeze activity when a small float and high short interest combine with buying pressure. Sector-wide momentum in biotech could have lifted a previously depressed stock. Alternatively, an announcement from the company itself may exist but has not yet been indexed by the RSS feed source or Yahoo Finance. Without visibility into trading volume, short interest, or recent insider activity, the specific trigger remains unknown.

ALISR

Calisa Acquisition Corp Right

$0.64+$0.14

+27.7%

NASDAQ

No news headlines were reported in the last 48 hours, so the 27.72% jump in ALISR cannot be directly attributed to a specific announcement or event based on available information.

ALISR is a Calisa Acquisition Corp Right, meaning it is a warrant or right associated with a blank-check merger vehicle. The stock's sharp intraday gain without corresponding news coverage suggests the move was likely driven by factors common to SPAC-related securities: technical trading, positioning ahead of a merger announcement, redemption mechanics, or market sentiment shifts. Rights and warrants associated with SPACs are frequently volatile and can spike on relatively thin volume without accompanying news, particularly if there is forward-looking speculation about an imminent business combination or changes to deal terms. The absence of news does not rule out a private announcement to shareholders or insider activity that has not yet reached public headlines, but this cannot be confirmed from the evidence provided.

CNET

ChinaNet Online Holdings IncCommunication Services

$0.99+$0.21

+27.4%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 27.41% gain likely reflects technical or market-driven factors such as short covering, a delayed announcement, or retail trading activity in a low-priced, low-volume stock.

The absence of recent news is notable given CNET's significant single-day rally to the number 10 ranking of gainers. For a micro-cap stock trading at $0.99, large percentage moves can occur with relatively modest absolute volume. This type of move in a news vacuum typically stems from technical factors such as short squeeze pressure, oversold technical bounce, a rumored but unconfirmed development, or broad sector rotation into China-focused or technology names. Without confirmation from company announcements or substantive reporting, attribution remains speculative. The stock's low price and likely modest liquidity mean that even modest share buying can generate outsized percentage gains.

EUDA

Euda Health Holdings LimitedReal Estate

$19.00+$4.01

+26.8%

NASDAQ · Mkt cap $42 M

No news headlines were found in the last 48 hours for EUDA, so the 26.75% gain likely reflects a delayed market reaction to an earlier announcement, technical trading, or untracked developments in healthcare or biotech sectors.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to a specific catalyst for the jump. However, EUDA operates in health holdings, a sector where regulatory approvals, clinical trial results, partnership announcements, or merger activity can drive outsized moves. The stock's 26.75% gain and ranking as the 11th biggest gainer suggests meaningful volume and interest. Possible explanations include a delayed market reaction to news released before the 48-hour window, short covering if the stock has significant short interest, technical break-out momentum, or an announcement that has not yet appeared in RSS feeds or major financial news aggregators. Without access to the company's investor relations channels or real-time trading data, we cannot distinguish between these scenarios.

REBN

Reborn Coffee, Inc.Consumer Cyclical

$1.26+$0.26

+26.3%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 26% gain likely reflects either a technical rebound, retail interest, or an untracked announcement, but the specific catalyst cannot be identified from available evidence.

Reborn Coffee gained 26.29% to rank among the top 12 gainers on July 27, 2026, yet no relevant news appeared in the Yahoo Finance RSS feed over the prior 48 hours. This absence of disclosed catalysts makes the move difficult to attribute with confidence. For a micro-cap coffee company trading at $1.26, typical drivers of sharp single-day rallies include delayed or off-channel announcements, technical bounces after oversold conditions, options-related activity, or social media-driven retail momentum. Without access to insider filings, press releases outside major news wires, or real-time trading data, we cannot distinguish between these scenarios. The lack of news coverage does not rule out a material event; it suggests the event either occurred through less-tracked channels or the move was driven by sentiment and technicals rather than new information.

INLF

INLIF LIMITEDIndustrials

$3.25+$0.80

+25.1%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 25% gain likely reflects either a technical bounce, a delayed market reaction to an older announcement, or unconfirmed market rumor.

INLIF displayed a strong single-day rally of 25%, rising to $3.25, yet no recent news headlines are available to explain the move. This disconnect is notable. For a microcap or thinly-traded stock like this, sharp gains can occur due to several categories of catalyst: delayed disclosure of a positive development (earnings beat, partnership, regulatory approval, or financing), short covering in a stock with high short interest, retail or momentum-driven buying following a technical breakout, or unverified rumors circulating on message boards or social media. Without access to press releases, SEC filings, or other news sources beyond Yahoo Finance's last 48 hours, it is not possible to identify a specific trigger. The absence of news coverage itself may indicate the catalyst is either very recent, very localized to retail traders, or not yet formally disclosed.

Skycorp Solar Group Limited Ordinary SharesEnergy

$9.88+$1.88

+23.5%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 23.5% gain likely reflects either delayed reporting of an announcement, technical/sentiment-driven movement in a solar sector stock, or market-moving information not yet captured by Yahoo Finance RSS.

The absence of recent headlines despite a significant single-day gain of 23.5% for Skycorp Solar Group makes direct attribution impossible. Solar stocks are historically sensitive to several categories of catalyst: policy announcements affecting renewable energy incentives or subsidies, earnings surprises, contract wins, or shifts in commodity prices affecting solar panel costs. Given the lack of news in the provided sources, the move could reflect a combination of factors including delayed public disclosure of company-specific information, sector rotation into clean energy equities, or technical momentum in a smaller-cap stock. Without concrete news evidence, we cannot distinguish between fundamentally driven appreciation and momentum-based movement.

AIIOW

NWTN Inc. WarrantConsumer Cyclical

$0.03+$0.01

+23.2%

NXTC

NextCure IncHealthcare

$5.21+$0.95

+22.3%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 22.3% gain on NXTC likely stems from either a delayed announcement, technical rebound, or market-level movement not yet reflected in major news feeds.

The absence of recent news in the Yahoo Finance RSS feed creates a data gap that prevents direct attribution of the jump. NextCure is a clinical-stage immunotherapy company, and biotech stocks of this type typically respond sharply to clinical trial updates, regulatory decisions, partnership announcements, or funding news. The magnitude of the move—ranking 16th among daily gainers—suggests a meaningful catalyst rather than routine trading. However, without confirmed headlines, possibilities include an announcement made outside the sampled news window, a pre-market or after-hours disclosure not yet indexed by the feed, technical buying on previous oversold conditions, or sector-wide biotech momentum. The stock's history and pipeline composition would normally be relevant context, but that information is not provided here.

ASPU

Aspen Group Inc-COConsumer Defensive

$0.32+$0.06

+21.1%

NASDAQ · Mkt cap $7.6 M

No news headlines were found in the last 48 hours, so the 21% gain on ASPU likely reflects a technical rebound, short covering, or undetected announcement not yet indexed by the major news feed.

The absence of any news headlines in the past two days makes it difficult to pinpoint a specific catalyst for ASPU's 21% gain. For a micro-cap stock trading at $0.32, price moves of this magnitude are not uncommon and can be driven by several factors that may not immediately surface in major news aggregators. Possible explanations include technical oversold conditions triggering a rebound, short-squeeze activity given the stock's low price and likely high short interest, delayed earnings or guidance updates that have not yet been picked up by Yahoo Finance RSS, insider buying, or progress on business developments that were announced earlier but are now being re-rated by the market. Without substantive headline support, any specific cause remains speculative.

LUCY

Innovative Eyewear, Inc.Healthcare

$0.79+$0.14

+20.9%

NASDAQ · Mkt cap $2.7 M

No news headlines were found in the last 48 hours, so the 20.93% gain in LUCY stock cannot be directly attributed to a specific disclosed event. The move may reflect technical momentum, short covering, or undisclosed developments.

The absence of recent news headlines in the provided data makes it impossible to pinpoint a concrete catalyst for LUCY's sharp 20.93% intraday rally. Innovative Eyewear is a micro-cap stock trading at $0.79, and stocks at this price point are particularly sensitive to retail interest, short squeezes, and technical breakouts. Potential explanations fall into two broad categories. First, the move could be technical in nature: a support bounce, momentum ignition above a key level, or retail attention triggered by social media or scanner alerts. Second, it could reflect material information—such as clinical trial results, a partnership announcement, earnings, or insider activity—that has not yet propagated to the Yahoo Finance RSS feed or was released through non-traditional channels. Without access to press releases, company filings, or proprietary news sources, attributing this move to a specific business catalyst remains speculative. The timing of entry into the top 20 gainers may itself attract further retail buying, creating a self-reinforcing momentum loop.

SFWL

Shengfeng Development Limited - Class A Ordinary SharesIndustrials

$0.84+$0.14

+20.4%

NASDAQ · Mkt cap $73 M

No news headlines were found in the last 48 hours, so the 20.35% gain on SFWL likely reflects a technical bounce, delayed reaction to an earlier announcement, or short covering in a low-liquidity microcap stock.

The absence of any recent news headlines makes it impossible to attribute the jump to a specific corporate event such as earnings, guidance, financing, or product news. SFWL trades on NASDAQ but as a micro-cap security trading near $0.84, it typically exhibits high volatility and thin liquidity. Stocks in this price and market-cap range are prone to sharp single-day moves driven by technical factors such as oversold bounces, short covering, or retail interest shifts rather than fundamental news. The stock may have been down significantly in recent days, triggering a reversal, or there may be a delayed market reaction to news not yet indexed by the RSS feed. Without access to the stock's recent price history or trading volume context, we cannot distinguish between these scenarios. A direct check of the company's investor relations materials or SEC filings would be needed to confirm whether an announcement was made outside the 48-hour window.

Missfresh LimitedCommunication Services

$6.13+$1.03

+20.2%

NASDAQ · Mkt cap $27 M

No news headlines were available in the last 48 hours to explain Missfresh's 20.2% gain on July 27, 2026, so the catalyst remains unclear without additional reporting or market data.

Missfresh Limited, a Chinese fresh produce e-commerce platform, jumped 20.2% to rank among the day's top 20 gainers, but the Yahoo Finance RSS feed returned no relevant headlines in the preceding 48 hours. This absence of reported news is notable and suggests the move was either driven by a catalyst not yet picked up by major news aggregators, a delayed market reaction to older news, or a technical/sentiment-driven move. For a stock in the competitive and volatile Chinese e-commerce sector, typical catalysts would include earnings beats or guidance raises, operational turnarounds, changes in regulatory environment affecting cross-border commerce, or short-covering if the stock had been heavily shorted. Without substantive reporting, any specific explanation would be speculative.

QBTS

D-Wave Quantum Inc.Technology

$19.50+$3.27

+20.1%

NYSE · Mkt cap $6.2 B

D-Wave Quantum surged 20.15% on July 27 following announcement of an expanded partnership with AT&T to deploy its quantum annealing systems for network optimization tasks including outage detection and traffic management, marking concrete commercial traction in the quantum computing sector.

Multiple headlines from July 27 converge on a single catalyst: D-Wave announced an expanded deal with AT&T to deploy quantum annealing technology for network operations optimization. This represents validation of commercial viability rather than theoretical promise. The news sources emphasize that "commercial traction is often the strongest signal of progress" in quantum computing and that AT&T's expansion—following a successful 15-second test—signals the technology is moving from R&D to production use. Analyst commentary suggests the quantum sector is reaching a "tipping point" with projected $1.5 billion revenue in 2026. The stock had snapped a three-day losing streak, and the deal appears to have resolved investor uncertainty about D-Wave's path to revenue generation and market adoption. The timing of earnings visibility discussion in the same news cycle suggests the market may also be anticipating strong Q2 results tied to this partnership momentum.

KRSP.WT

$1.23+$0.21

+20.1%

EONR.WT

EON Resources Inc WT

$0.10+$0.02

+19.8%

YSXT

YSX Tech. Co., Ltd Class A Ordinary SharesIndustrials

$1.03+$0.17

+19.8%

NASDAQ · Mkt cap $35 M

No news headlines were published about YSXT in the last 48 hours, so the 19.77% gain likely stems from technical trading, sector momentum, or undisclosed catalysts.

The absence of recent news in the Yahoo Finance RSS feed is notable for a stock that jumped nearly 20% and ranked among the top 25 gainers on the day. This suggests the move was not driven by a major announced corporate event such as earnings, guidance revision, partnership, or regulatory approval. For micro-cap or lower-liquidity stocks like YSXT trading near $1, price moves of this magnitude can occur from relatively modest volume shifts, algorithmic rebalancing, options positioning, or renewed retail interest following a period of decline. Without access to intraday volume data, trade sources, or commentary from market participants, it is difficult to pinpoint the specific trigger. The move could reflect delayed market reaction to an older announcement, short-covering, sector rotation, or simply technical momentum in a lightly traded name.

VGAS

Verde Clean Fuels, Inc. - Class A Common StockUtilities

$1.13+$0.19

+19.6%

NASDAQ · Mkt cap $58 M

No news headlines were found in the last 48 hours for VGAS, so the 19.63% gain on July 27 cannot be directly attributed to a disclosed catalyst; the move likely reflects technical trading, sector rotation, or undisclosed market activity.

The absence of recent news headlines makes it impossible to point to a specific corporate event or announcement as the cause of this substantial single-day gain. Verde Clean Fuels operates in the clean fuels and alternative energy space, which can be subject to sector-wide momentum shifts, short-squeeze activity, or technical breakouts that drive large percentage moves in thinly traded or lower-priced stocks independent of fundamental news. Given VGAS's position as the 25th biggest gainer on the day, the move could reflect broad investor rotation into clean energy names, a technical chart breakout, covering of short positions, or social media attention, but without access to news wires, SEC filings, or real-time market data beyond the price action itself, the specific trigger remains unidentified.

VACI.WT

Viking Acquisition Corp. I WT

$0.80+$0.13

+19.4%

UMAC

Unusual Machines, Inc.Technology

$20.56+$3.30

+18.9%

NYSE · Mkt cap $1.2 B

No news headlines were found in the last 48 hours for UMAC, so the 18.90% intraday gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, market rumors, or delayed news not yet indexed.

The absence of recent news headlines for Unusual Machines on Yahoo Finance makes it impossible to pinpoint a definitive cause for today's 18.90% surge. Smaller-cap or micro-cap stocks like UMAC frequently experience outsized moves driven by technical factors such as short covering, momentum accumulation, or retail trading activity concentrated in social media communities. Alternatively, the move could stem from a delayed earnings release, an analyst upgrade, or company-specific news that has not yet propagated through major financial news feeds. Without confirmed information, any explanation remains speculative. Investors should verify whether news was released through the company's investor relations channels, regulatory filings, or press releases before concluding the move is purely technical or rumor-driven.

ICON

Iconix Brand Group IncIndustrials

$1.15+$0.18

+18.6%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours, so the 18.56% gain appears driven by technical factors, rumors, or delayed market reaction to an earlier event not captured in the RSS feed.

The absence of any recent news in the provided headlines makes it difficult to pinpoint a specific catalyst for ICON's 18.56% surge. For a micro-cap branded apparel and licensing company like Iconix, price movements of this magnitude often reflect technical overshooting in thinly traded names, short covering, or sentiment shifts tied to restructuring progress or licensing revenue developments. Without current headlines, the most likely explanations fall into two categories: first, a delayed market reaction to news released before the 48-hour window; second, a technical or sentiment-driven bounce in a stock that may trade on low volume, making percentage moves easier to achieve. The company has faced significant challenges historically, so any perceived improvement in its licensing portfolio or debt situation could trigger sharp reversals in speculative positioning.

IMMR

Immersion CorpTechnology

$7.74+$1.21

+18.5%

NASDAQ · Mkt cap $252 M

Immersion Corporation reported fourth quarter and fiscal 2026 results on July 27, likely driving the 18.53% gain, though the actual earnings figures and guidance changes are not detailed in the headline provided.

The company released its Q4 and full fiscal 2026 financial results on the same day as the stock's 18.53% surge, ranking it the 29th biggest gainer. This timing strongly suggests the earnings announcement was the catalyst. However, the headline provided does not include specific metrics such as revenue, earnings per share, profitability, margin expansion, guidance raises, or contract wins that would explain investor enthusiasm. Immersion is a haptics licensing company, and such firms typically move on licensing deal announcements, royalty revenue surprises, or guidance improvements. The magnitude of the gain (18.53%) suggests material positive news rather than a minor beat, but without access to the actual earnings release details, we cannot confirm what specifically drove the move.

RACC

Research Alliance Corporation IIIFinancial Services

$13.28+$2.03

+18.5%

NASDAQ · Mkt cap $256 M

RACC announced a business combination agreement with Oak Hill Bio to create a publicly listed rare disease biotech company focused on antisense oligonucleotide therapy, providing Oak Hill with $175 million in gross proceeds backed by RACC's trust account, driving an 18.45% gain.

The headline establishes a definitive M&A catalyst: RACC, a NASDAQ-listed blank-check company or SPAC, has agreed to merge with Oak Hill Bio, a private rare disease biotechnology firm. The transaction delivers $175 million in gross proceeds to Oak Hill, with $75 million sourced from RACC's trust account and fully backstopped, suggesting strong sponsor support and certainty of execution. The combined entity will advance rugonersen, an antisense oligonucleotide therapy targeting Angelman Syndrome, a rare genetic disorder. SPAC mergers and biotech M&A typically attract investor interest through exposure to rare disease indications with high unmet medical needs and potential for orphan drug designations. The 18.45% single-day move is consistent with positive market reception of the deal structure and the therapeutic focus.

GRSD

Grandstand LimitedConsumer Cyclical

$1.97+$0.31

+18.4%

NASDAQ · Mkt cap $73 M

Grandstand announced its Q2 2026 earnings release date for August 13, which likely triggered a technical rally in this thinly-traded micro-cap stock ahead of results disclosure.

The only news event in the past 48 hours is Grandstand's announcement that it will report second quarter 2026 results on August 13 and host a conference call. This is a routine earnings calendar announcement with no new operational data or guidance provided. However, for micro-cap stocks trading at $1.97 with presumably low liquidity, such announcements can catalyze technical rallies as investors position ahead of earnings or as algorithmic systems flag the stock as a mover. The 18.37% gain is substantial but not uncommon for stocks in this price and market-cap range. Without access to short interest, trading volume, or insider transaction data, the move could reflect genuine investor interest in upcoming results, covering of short positions, or simple technical momentum in a lightly-traded name. The announcement itself provides no new business information.

TRAX

First Tracks Biotherapeutics, Inc.Healthcare

$41.98+$6.49

+18.3%

NASDAQ · Mkt cap $1.5 B

No news headlines were published in the last 48 hours for TRAX, so the 18.27% gain cannot be attributed to a specific disclosed event. The move likely reflects technical trading, delayed news dissemination, or market sentiment shift in the biotech sector.

The absence of any news headlines in the Yahoo Finance feed over the past two days is notable given the substantial single-day gain of 18.27% that placed TRAX as the 32nd largest gainer on NASDAQ. For a biotherapeutics company, typical catalysts would include clinical trial data releases, FDA decisions, partnership announcements, or earnings results. Without headlines in the provided feed, several possibilities exist. First, the news may have been published through channels not captured by this RSS feed, or the timing lag between announcement and feed indexing may have created a gap. Second, the move could be driven by technical factors such as short covering, options-driven gamma pressure, or momentum trading in response to earlier developments not shown here. Third, the stock could be responding to broader biotech sector strength or market sentiment shifts. Without concrete evidence of a specific catalyst, any attribution remains speculative.

ZVZZT

$15.42+$2.37

+18.1%

BYRN

BYRNA TECHNOLOGIES INC.Industrials

$4.14+$0.62

+17.6%

NASDAQ · Mkt cap $89 M

The provided headline does not identify a specific catalyst for BYRNA's 17.61% jump. The article is a generic industrial-sector feature mentioning BYRNA among other stocks without detailing any company-specific news or announcement.

The single headline is a general editorial piece about industrial stocks with unrealized potential, noting that the sector is sensitive to macroeconomic factors like interest rates. It does not attribute any particular event, earnings result, product announcement, contract win, or guidance change to BYRNA. The headline appears to be a broad sector-level article rather than company-specific news. Without information about earnings surprises, insider buying, short-squeeze activity, analyst upgrades, or other concrete catalysts, we cannot pinpoint the cause of today's move. Possibilities include market sentiment around interest rates mentioned in the piece, technical trading, retail investor interest, or an unrelated intraday event not captured in the Yahoo Finance RSS feed provided.

GGRP

Glimpse Group, Inc.Technology

$0.94+$0.15

+17.3%

LAES

SEALSQ Corp - Ordinary SharesTechnology

$2.49+$0.36

+16.9%

NASDAQ · Mkt cap $579 M

No news headlines were found in the last 48 hours, so the 16.90% gain on LAES appears driven by factors other than published company announcements or major news events.

SealSQ Corp showed a significant single-day gain with no corresponding headlines in the search window, which points to either delayed news indexing, technical factors, or market microstructure effects. Small-cap semiconductor and cybersecurity stocks like LAES can be volatile and responsive to sector momentum, short covering, or contract wins that may not immediately appear in major news feeds. Another possibility is a conference presentation, earnings date approach, or insider activity that triggered algorithmic or retail interest. Without specific news anchoring the move, it is impossible to identify the precise catalyst, though the stock's position in security and IoT markets means product announcements, partnership news, or guidance updates are typical catalysts for this issuer.

EDHL

Everbright Digital Holding Limited Ordinary SharesCommunication Services

$3.88+$0.60

+16.7%

NASDAQ · Mkt cap $6.5 M

Everbright Digital announced an $8.07 million public offering on July 26, which likely triggered the 16.66% gain on July 27 as investors may have viewed the capital raise as a positive catalyst for growth or responded to renewed investor interest in the stock.

The only substantive news in the provided headlines is Everbright Digital's announcement of a public offering priced at $8.07 million. The headline text is truncated, so we lack details on the offering terms, use of proceeds, dilution impact, or any forward guidance that might accompany the announcement. Public offerings can be viewed positively or negatively depending on context: capital raises sometimes signal management confidence in growth prospects or provide runway for expansion, while they typically dilute existing shareholders. The magnitude of the gain (16.66%) is notable and suggests the market interpreted this particular offering favorably, though without the full press release we cannot pinpoint the specific factors driving sentiment. It is also possible the gain reflects technical momentum, short covering, or other market factors independent of the offering itself.

NMPAR

NMP Acquisition Corp. Right

$0.20+$0.03

+16.5%

NASDAQ

No news headlines were found in the last 48 hours, so the 16.53% gain in NMPAR (a SPAC rights unit) likely reflects either technical trading activity, broader market sentiment shifts affecting SPAC-related securities, or delayed news not yet captured in the RSS feed.

NMPAR is a rights unit associated with NMP Acquisition Corp., a special purpose acquisition company structure. Without any news headlines provided from the past 48 hours, we cannot point to a specific catalyst such as a merger announcement, deal termination, or business update. Rights units in SPACs are typically lower-priced and lower-liquidity instruments that can exhibit outsized percentage moves on modest dollar volume. The 16.53% gain could reflect short covering in a thinly traded security, retail interest in SPAC-related plays, or correlation with broader movements in blank-check company valuations. It is also possible that relevant news exists but was not captured by the Yahoo Finance RSS feed during the snapshot period.

AIOS

NiSun International Enterprise Development Group Co., Ltd. Class AFinancial Services

$12.21+$1.71

+16.3%

NASDAQ · Mkt cap $2.7 M

About AIOS Tech Inc.

Listed in this day's movers as “NiSun International Enterprise Development Group Co., Ltd. Class A” — the company profile carries a different name (rename, or the ticker changed hands). The read below follows the profile.

AIOS Tech Inc. functions as an investment holding company, providing technology-centric integrated financing solutions and comprehensive supply chain services throughout China. The company specializes in offering sophisticated financing services to small and medium-sized enterprises (SMEs). This includes the conceptualization and detailing of debt financial products, alongside providing strategic advisory to underwriters and various financial institutions. Furthermore, AIOS facilitates the entire financing process, from initial due diligence and regulatory registration to client acquisition, investor education, and crucial intermediary and advisory matching services. On the supply chain front, the company leverages cutting-edge technologies such as big data, artificial intelligence (AI), the Internet of Things (IoT), and blockchain. These innovations underpin its supply chain management solutions, primarily serving sectors like agriculture, infrastructure, maritime logistics, energy, and plastics products. Beyond management, AIOS engages in extensive supply chain trading across diverse industries, including agriculture, coal, new energy technology, construction, e-commerce, retail, and the food and vegetable sectors. Additionally, through its Huijingshe platform, the company provides direct banking services, specializing in asset allocation and financial planning for both institutional and individual investors. Rounding out its portfolio, AIOS offers a wide array of auxiliary services. These range from customer management, consulting, and advisory support to comprehensive product inspection, testing, documentation, and freight forwarding. The company also handles customs clearance, warehousing, strategic planning, sourcing, procurement, and all aspects of logistics and transportation, including storage. Formerly known as Nisun International Enterprise Development Group Co., Ltd., the company officially adopted the name AIOS Tech Inc. in February 2026. Established in 2005, its operations are headquartered in Shanghai, China.

Financial - Credit Services · ir.aiosinc.com

No news headlines were available in the last 48 hours for AIOS, so the 16.29% gain cannot be attributed to a specific announced event. The move likely stems from technical factors, delayed news pickup, or market rumors.

The absence of recent news coverage makes it difficult to pinpoint a definitive catalyst for AIOS's strong single-day gain of 16.29%. For a smaller-cap stock like NiSun International, such moves can be driven by several non-news factors: short covering if the stock had significant short interest, technical breakout from support levels, options-related hedging activity, or delayed market reaction to earlier announcements not yet syndicated to major feeds. It is also possible that material news exists but has not yet been picked up by Yahoo Finance's RSS feed, or that the move reflects intraday momentum unrelated to fundamental developments. Without access to the company's investor relations channels or trading volume data, we cannot distinguish between these scenarios.

OMER

Omeros CorpHealthcare

$11.34+$1.56

+16.0%

TVGN

Semper Paratus Acquisition CorporationHealthcare

$5.15+$0.69

+15.4%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 15.36% gain on Semper Paratus Acquisition Corporation (TVGN) cannot be attributed to a specific announced catalyst. The move likely reflects either a delayed market reaction to older news, technical trading, or speculation.

The absence of recent news coverage makes it difficult to pinpoint a definitive cause for today's sharp move. TVGN is a SPAC (special purpose acquisition company), a class of security that can experience volatile trading on thin volume, rumor, or technical triggers unrelated to fundamental developments. Possible explanations include: first, a delayed market reaction to news or an announcement made before the 48-hour window or distributed through channels not captured in this RSS feed; second, technical trading or short covering if the stock had accumulated short positions; third, insider activity or unannounced corporate development that has not yet become public. SPACs in particular can gap sharply on merger speculation or deal completion milestones. Without corroborating headlines, all such explanations remain speculative.

LSE

Leishen Energy Holding Co., Ltd. Ordinary SharesEnergy

$4.94+$0.65

+15.2%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 15.15% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading, or market sentiment shift not captured in the available headlines.

The absence of any news in the last 48 hours makes it difficult to pinpoint a specific catalyst for LSE's strong 15.15% gain. For a microcap or thinly traded stock like Leishen Energy, moves of this magnitude can be driven by several non-news factors: short covering, options-related positioning adjustments, volume spikes in low-float stocks, or delayed market digestion of company announcements that haven't yet surfaced in major financial RSS feeds. It is also possible that news was released on a company website or press release service but has not yet been indexed by Yahoo Finance's RSS feed, creating a lag between the event and its appearance in widely-tracked news aggregators. Without confirmatory headlines, the move remains unattributed to any specific event.

AIB

AIB Acquisition CorporationTechnology

$1.85+$0.24

+15.1%

CHPGR

ChampionsGate Acquisition Corporation Rights

$0.15+$0.02

+14.9%

NASDAQ

No news headlines were found in the last 48 hours, so the 14.85% gain cannot be directly attributed to a disclosed event. The move may reflect technical trading activity, SPAC-related catalysts, or delayed news circulation on this micro-cap rights offering.

ChampionsGate Acquisition Corporation Rights is a SPAC rights security trading at $0.15, a micro-cap instrument with typically low liquidity and high sensitivity to small share volume changes. The absence of recent news headlines means no earnings, merger, regulatory, or guidance announcement can be confirmed as the cause. Rights offerings on SPACs often move on speculation about underlying merger progress, redemption dynamics, or warrant conversion activity rather than hard news. The 14.85% single-day move in a sub-$0.20 security could reflect large percentage moves from modest absolute dollar volume, institutional positioning changes, or options-related hedging. Without verifiable headlines or access to intraday data, any specific catalyst remains unconfirmed.

RYOJ

RYOJBABA CO LTDIndustrials

$3.95+$0.58

+14.8%

NASDAQ · Mkt cap $53 M

No financial news was reported in the last 48 hours for RYOJ, so the 14.8% gain likely stems from technical factors, short covering, retail interest, or an untracked announcement outside major news channels.

Yahoo Finance RSS returned no headlines for RYOJ in the prior 48 hours, which means this significant single-day jump cannot be attributed to a disclosed earnings report, merger announcement, regulatory action, or other major corporate event in the public record during that window. For a micro-cap or thinly traded stock like this, a large percentage move absent news headlines typically reflects either technical buying driven by chartist breakouts or moving-average crossovers, short-squeeze dynamics if the stock has meaningful short interest, retail trading momentum from social media or trading forums, or an announcement posted directly by the company or discussed on investor boards but not yet picked up by major financial news aggregators. Without additional context on the stock's float, short interest, recent technical setup, or volume profile, no single explanation can be confidently assigned.

DCX

Chijet Motor Company, Inc.Consumer Cyclical

$0.72+$0.09

+14.0%

NASDAQ · Mkt cap $322 M

No news headlines were found in the last 48 hours for Chijet Motor Company, so the 13.96% gain likely reflects a technical rebound, retail interest, or untracked developments rather than a major announced catalyst.

The absence of any Yahoo Finance news in the past two days means we cannot identify a specific corporate event driving the move. Chijet Motor Company operates in the competitive automotive sector and trades at a low price point of $0.72, characteristics typical of microcap or recovery stocks prone to volatility. The jump could reflect several common causes in this category: a short-squeeze or reversal of prior selling pressure, positive momentum from the broader market or sector, delayed news not yet syndicated to major feeds, social media activity or retail trader interest, or a response to an earnings date or earnings release posted directly to the company website without immediate Yahoo syndication. Without additional context on Chijet's recent performance, short interest, or announced events, attribution remains speculative.

BUUU

BUUU Group LimitedIndustrials

$22.99+$2.79

+14.0%

NASDAQ · Mkt cap $474 M

No headlines were found in the last 48 hours, so the cause of BUUU's 13.95% gain cannot be directly attributed to a news event. The jump may reflect a technical rebound, delayed market reaction to an earlier announcement, or trading activity unrelated to public information.

The absence of recent news headlines means we cannot point to a specific catalyst such as earnings, guidance, a contract win, or regulatory action. For a stock like BUUU Group Limited trading on NASDAQ with a notable single-day gain to the top 50 movers, the jump could reflect several categories of activity: a technical bounce after oversold conditions, short covering or retail buying interest, a delayed market reaction to news released before the 48-hour window, or general sector rotation. Without access to intraday price action, volume data, or institutional positioning, identifying the precise trigger remains speculative. The stock's rank as the 47th biggest gainer suggests material volume participation, but that alone does not clarify the underlying reason.

MLCI

Mount Logan Capital Inc.Financial Services

$3.23+$0.41

+13.9%

NASDAQ · Mkt cap $35 M

Mount Logan Capital received an AM Best B+ "Good" financial strength rating and bbb- issuer credit rating for its insurance subsidiary, a regulatory validation that likely drove the 13.95% gain as it validates the company's insurance platform viability.

The headline announces a significant milestone: AM Best, a major rating agency for insurance companies, assigned Ability Insurance Company a B+ financial strength rating and bbb- long-term issuer credit rating. This is characterized in the news excerpt itself as "a significant milestone" that highlights improvement to Mount Logan's insurance solutions platform. For insurance-linked businesses, third-party credit ratings from established agencies like AM Best carry outsized weight because they signal regulatory approval, financial stability, and competitive credibility. A "Good" rating from AM Best removes a key validation risk and likely opens doors for partnerships, capital raising, or customer acquisition. The timing and newness of the rating (announced same day as the stock move) strongly suggests this is the direct catalyst rather than a delayed reaction to older news.

SAIH

SAIHEAT LimitedTechnology

$16.87+$2.05

+13.8%

NASDAQ · Mkt cap $40 M

No news headlines were found in the last 48 hours for SAIH, so the 13.83% gain likely reflects either a delayed market reaction to an unreported announcement, technical trading, or speculation unrelated to publicly available information.

The absence of any news coverage in Yahoo Finance's RSS feed over the past two days makes it difficult to pinpoint a specific catalyst for SAIH's strong 13.83% rally. The stock ranked as the 49th biggest gainer on the day, suggesting real trading volume and interest. Without headlines, plausible explanations include a delayed or embargoed earnings release, an announcement made through alternative channels not yet picked up by Yahoo Finance, short covering, or retail investor attention driven by social media or other non-traditional sources. For a smaller-cap or lower-coverage stock like SAIH, material news sometimes takes time to propagate through major financial wire services, or announcements may be made directly via press release without immediate headline distribution. Technical factors such as options expiration, rebalancing, or gap-fill moves are also possible contributors. However, without corroborating information, these remain speculative.

VRXA

Veraxa Biotech AGHealthcare

$2.04+$0.25

+13.7%

NASDAQ · Mkt cap $260 M

VERAXA announced advancement of its bispecific antibody-drug conjugate program VXA-222 to the next phase following a key technical milestone with OmniAb, driving the 13.69% single-day gain.

The company released news on July 27 that its VXA-222 program reached a technical milestone and advanced into the next phase of development under its collaboration with OmniAb. This is a clinical/preclinical catalyst typical for biotech stocks, signaling progress in a novel oncology program. The stock's placement at 50 biggest gainer suggests moderate but meaningful investor interest. Bispecific antibody-drug conjugates represent a promising therapeutic class, and milestone achievement typically triggers positive sentiment. However, the headlines provided do not disclose the specific nature of the milestone, efficacy data, timeline expectations, or financial implications. The move appears reasonable for a clinical-stage program hitting a de-risking milestone, though the magnitude depends on prior expectations and investor positioning.

Biggest Losers

Mon, Jul 27, 2026 50

BIOT

Biotech Acquisition CompanyConsumer Defensive

$2.77−$12.73

-82.1%

CISS

C3is Inc. - Common StockIndustrials

$0.11−$0.40

-76.3%

NASDAQ · Mkt cap $4.6 M

C3is Inc. announced a $6.0 million underwritten public offering on July 27, which typically causes sharp dilution-driven sell-offs in small-cap stocks, explaining the 76% single-day collapse.

The headline confirms C3is announced the pricing of a $6.0 million underwritten public offering on the same day as the collapse. In small-cap and micro-cap equities, secondary offerings announced at or near market prices almost invariably trigger immediate and severe sell-offs due to shareholder dilution concerns and negative sentiment around capital raising. The stock's low absolute price of $0.11 suggests this is a distressed or speculative security where equity raises are viewed with particular skepticism. The timing of the announcement (13:30 UTC on July 27) aligns with the same-day 76% drop. While the headline does not disclose the offering price relative to the pre-announcement price or the percentage dilution, the magnitude of the decline is consistent with typical market reactions to dilutive equity raises in this market segment. No earnings, guidance, contract wins, or operational news is present to explain an alternative narrative.

MPLT

MapLight Therapeutics, Inc.Healthcare

$9.91−$26.46

-72.4%

NASDAQ · Mkt cap $525 M

MapLight Therapeutics announced positive Phase II trial results for its schizophrenia drug ML-007C-MA on July 27, yet the stock plummeted 72% the same day, suggesting the market viewed the results as insufficient to justify the prior valuation or expected better efficacy data.

The headline sequence is striking: MapLight released three nearly identical announcements on July 27 stating that its Phase II ZEPHYR trial of ML-007C-MA met its primary endpoint with statistically significant improvement in PANSS total score at the 210/3 mg twice-daily dose. By conventional biotech standards, a successful Phase II primary endpoint for a schizophrenia treatment should be positive news. However, the stock fell 68-72% on the same day. This severe disconnect suggests the market either (a) expected larger or more clinically meaningful efficacy gains than the data showed, (b) had already priced in success and sold on the announcement, (c) identified safety or dosing concerns in the detailed results not highlighted in headlines, or (d) concerns emerged about competitive positioning or regulatory pathway. A July 26 article noted the stock had recently traded near $36.56, implying a pre-announcement price around that level. The available headlines do not provide the actual efficacy magnitude, safety profile, or comparative context needed to assess why positive Phase II data triggered such severe selling.

YYAI

Connexa Sports Technologies Inc.Technology

$3.10−$8.00

-72.1%

NASDAQ · Mkt cap $3.9 M

AiRWA announced a $130 million acquisition of Best Life, an import-export company, to diversify beyond its AI data training business, but the market reacted with a 72% sell-off, suggesting investor skepticism about the deal's strategic fit or valuation.

On July 27, AiRWA (YYAI) disclosed a definitive agreement to acquire Hongkong Best Life Trade Co., Limited for up to $130 million in upfront payments plus performance-based earn-outs. The stated rationale was to complement its AI data training business and diversify revenue. However, the market's response was severe: a 72% single-day decline places this among the day's worst performers. The headlines provided do not explain investor objections directly. Possible inferences include concern that a $130 million acquisition (with additional earn-out exposure) represents poor capital allocation for the company's stated priorities, doubt about synergy between AI data training and import-export operations, dilution concerns, or weakness in the AI company's standalone business fundamentals that prompted the pivot. Without access to the deal structure, dilution metrics, or analyst commentary, the precise catalyst remains partially opaque, though the timing of the announcement and magnitude of the sell-off suggest the market viewed this as significantly value-destructive.

OMH

Ohmyhome Limited - Ordinary SharesReal Estate

$0.14−$0.40

-68.8%

NASDAQ · Mkt cap $7.7 M

Ohmyhome announced a $4 million registered direct offering on the same day the stock collapsed 68.81%, suggesting dilution from the capital raise likely triggered the sharp selloff.

The company announced pricing of a $4 million registered direct offering on July 27, 2026, the exact date of the massive decline. Registered direct offerings typically involve the issuance of new shares at a discount to market price, which dilutes existing shareholders and often triggers immediate selling pressure. The timing of the announcement coinciding with the rank-5 biggest daily loss strongly suggests this capital raise was the primary catalyst. The announcement itself provides limited detail in the excerpt provided, but the mechanism is well-established: investors facing dilution often exit positions immediately upon news of a direct offering, particularly in smaller-cap stocks where percentage dilution can be substantial relative to the share count. No other news or earnings-related catalyst appears in the provided headlines.

CAPR

Capricor Therapeutics IncHealthcare

$7.00−$12.70

-64.5%

NASDAQ · Mkt cap $464 M

FDA briefing documents released on July 27 raised significant concerns about the efficacy evidence for Capricor's lead therapy Deramiocel in treating Duchenne muscular dystrophy, triggering a sharp 64% single-day sell-off ahead of a critical advisory committee vote scheduled for July 29.

The stock collapse is directly tied to FDA staff reviewers' negative assessment of Deramiocel's clinical data, released publicly in briefing materials ahead of an advisory committee meeting. Multiple headlines confirm that FDA scientists questioned the effectiveness evidence for the therapy in treating cardiomyopathy in Duchenne patients, with some sources describing the FDA's analysis as painting an "ugly picture." Capricor responded by claiming the FDA used "obsolete" analysis methods, but this rebuttal has not arrested the decline. The advisory committee vote on July 29 represents a high-stakes binary outcome for the company, and the negative tone of the pre-meeting FDA briefing has created substantial doubt about approval odds among Wall Street analysts, who are now described as divided on the probability of success.

EGG

Enigmatig LimitedIndustrials

$2.06−$3.51

-64.4%

NYSE · Mkt cap $87 M

EGG dropped 64.4% with no news headlines in the last 48 hours, making the cause impossible to establish from available information. The move likely reflects an unannounced catalyst such as earnings disappointment, guidance cut, insider selling, or technical breakdown.

No recent news headlines are available to explain this severe single-day decline of nearly two-thirds of share value. A crash of this magnitude on a stock trading near $2 typically indicates a material negative catalyst such as an earnings miss, downward guidance revision, executive departure, disclosure of financial difficulties, regulatory setback, or technical breakdown among retail traders. Without access to company filings, press releases, or other news sources beyond the 48-hour Yahoo Finance feed provided, it is impossible to identify the specific trigger. The fact that EGG ranks as the seventh-biggest loser on the day suggests this was a broad market or sector event affecting multiple stocks, or an idiosyncratic event severe enough to rank among the day's worst performers despite a lack of visible headline coverage.

WETO

Webus International Limited Ordinary SharesTechnology

$0.04−$0.05

-53.5%

NASDAQ · Mkt cap $11 M

Webus (Weto) announced a warehouse robotics cooperation agreement supporting its Orchestra platform deployment with an estimated $5 million gross profit potential, yet the stock crashed 53.51%, suggesting market skepticism about execution or valuation concerns outweighed the positive development …

The company released two nearly identical announcements on July 27 detailing a new warehouse robotics partnership designed to support multi-site Orchestra project deployments, with management projecting approximately $5 million in project-level gross profit from the full rollout. On the surface this appears constructive: a named partnership addressing a previously announced strategic initiative with quantified upside. However, the catastrophic 53.51% single-day decline indicates the market either views the $5 million projection as insufficient given current valuation, questions the company's execution capability, interprets the partnership as a dilutive or subordinate arrangement, or the stock was already overleveraged on prior enthusiasm and this announcement merely triggered profit-taking or margin calls. The fact that both headlines arrived within hours of market open on the same day suggests coordinated disclosure rather than surprise news, yet the severity of the selloff points to deeper investor doubt about the company's business viability or path to profitability beyond isolated project wins.

OGGWZ

$0.08−$0.05

-49.3%

NASDAQ

No news headlines were found in the past 48 hours, so the 49% single-day drop cannot be attributed to a specific disclosed event; the cause remains unknown without additional reporting or structural context about this security.

OGGWZ experienced a severe one-day decline of 49.3% to $0.08 per share, but no recent news headlines are available to explain the move. At this price point and with minimal public information, several generic categories of catalyst are possible: the stock could have reacted to a delayed or late-breaking news item not yet indexed by the financial RSS feed, experienced a sharp reversal following technical breakdown, faced sudden liquidity or delisting concerns common to microcap securities, or responded to broader sector weakness or short-seller activity. Without access to company filings, press releases, or confirmed reporting beyond the headline search window, it is not possible to identify a specific triggering event. This appears to be a highly speculative or thinly traded security where price swings can be volatile and disconnected from traditional catalysts.

STAK

STAK Inc. Ordinary SharesEnergy

$2.55−$2.32

-48.3%

NASDAQ · Mkt cap $29 M

STAK plunged 48% with no news in the last 48 hours, suggesting either a delayed earnings miss, major corporate announcement released after market hours, or a technical/market-driven selloff without identified catalyst.

The absence of any headlines in Yahoo Finance's last 48-hour feed is notable given the magnitude of the decline—a nearly 50% drop would typically trigger immediate reporting if tied to earnings, guidance, regulatory action, or M&A. The stock trades on NASDAQ and ranks 10 in daily losers, indicating broad market visibility. Three plausible categories of cause warrant consideration: first, an earnings release or guidance cut that occurred outside the 48-hour window or was not yet captured by the RSS feed at time of analysis; second, an after-hours announcement or corporate action such as dilutive financing, reverse split, or management change; third, technical liquidation or short covering absent fundamental news. Without access to intraday filings, investor relations releases, or earlier market data, the specific trigger remains unidentified.

ALCE

Alternus Clean Energy, Inc.Utilities

$0.06−$0.05

-42.9%

NASDAQ · Mkt cap $43 K

No news headlines were found in the last 48 hours, so the cause of the 42.86% drop cannot be determined from available reporting. The move likely reflects technical selling, delayed news, or broader market pressure on micro-cap clean energy stocks.

The absence of any headlines in the last 48 hours makes it impossible to tie this severe drop to a specific corporate event. Alternus Clean Energy is a micro-cap renewable energy company trading at $0.06, a price point typical of distressed or highly speculative securities. Stocks at this valuation tier are prone to sharp moves driven by factors beyond mainstream news coverage: illiquidity-driven technical selling, delayed regulatory filings, insider transactions, or rumors confined to bulletin boards and social media. The scale of the loss (11th biggest loser of the day) suggests something material moved the market's view, but without corroborating headlines, whether that event was company-specific or part of a sector-wide repricing in clean energy stocks remains unknown.

BAOS

Baosheng Media Group Holdings Limited Ordinary sharesCommunication Services

$0.71−$0.46

-39.1%

NASDAQ · Mkt cap $799 K

No news headlines were found in the last 48 hours to explain the 39% decline in BAOS, so the cause remains unclear from available reporting.

BAOS experienced a severe single-day drop of 39%, placing it among the day's worst performers, but no news from Yahoo Finance RSS in the prior 48 hours provides a documented catalyst. For a micro-cap stock like BAOS trading at $0.71, sharp moves can reflect several patterns: delayed disclosure of corporate events, shifts in trading dynamics or short covering, technical forced selling following a technical breakdown, or off-exchange announcements not yet syndicated to major news feeds. Chinese media and regulatory stocks are also susceptible to sudden moves tied to government policy announcements or licensing decisions that may take time to reach US financial news aggregators. Without a specific headline or structural insight into the stock's position, the immediate driver remains unidentified.

COPL.WT

Copley Acquisition Corp WT

$0.08−$0.05

-36.9%

PFSA

Profusa, Inc.Healthcare

$1.22−$0.53

-30.5%

NASDAQ · Mkt cap $3.4 M

Profusa announced a major diagnostics acquisition via non-binding term sheet and leadership reshuffling on July 27, 2026, triggering a sharp 30.45% single-day sell-off, likely driven by dilution concerns, execution risk, or market skepticism about the strategic pivot.

The company disclosed two material events simultaneously: a non-binding term sheet to acquire a commercial-stage diagnostics company with approximately $111 million in 2025 net revenue, plus unspecified leadership changes. The pairing of major M&A activity with executive turnover often signals internal disagreement or investor concern about capital allocation. The use of "non-binding term sheet" suggests deal uncertainty and potential further dilution ahead. For a stock trading at $1.22 (likely low market cap), the acquisition of a $111 million revenue business may represent significant relative size, raising questions about financing, integration, and whether this represents a strategic departure from the core biosensing business. Market reaction reflects either skepticism about the acquisition's logic, concern about dilution to fund it, or loss of confidence in departing leadership. Without the full press release details on the new leadership or acquisition terms, the exact trigger remains partially opaque.

VCIG

VCI Global Limited - Ordinary ShareIndustrials

$0.44−$0.19

-29.9%

NASDAQ · Mkt cap $2.4 M

No news headlines were reported in the last 48 hours, so the 29.85% drop cannot be tied to a specific announced event. The decline likely stems from technical selling, market-wide pressure, or undisclosed company developments.

Yahoo Finance returned no headlines for VCIG in the 48-hour window covering this sharp decline. Without news context, the cause remains opaque. Stocks in the microcap space (trading at $0.44) are often subject to thin liquidity, technical reversals, and outsized moves on modest volume shifts. Possible drivers include delayed earnings misses or guidance cuts announced outside the headline feed, short-seller activity, dilutive financing announcements, or broad sector weakness. Penny stocks and low-priced OTC-traded securities can also experience sudden moves on rumor or insider trading ahead of unannounced news. Without corroborating headlines or SEC filings referenced in the provided data, any specific attribution would be speculation.

EJH

E-Home Household Service Holdings LimitedConsumer Cyclical

$1.39−$0.55

-28.3%

NASDAQ · Mkt cap $6.6 M

No news headlines were published in the last 48 hours, so the 28% drop cannot be attributed to a disclosed catalyst; the decline was likely driven by technical selling, low-liquidity mechanics, or undisclosed corporate news.

EJH experienced a severe one-day loss ranking it among the top 16 biggest losers on NASDAQ, yet no financial news, earnings releases, regulatory filings, or corporate announcements appeared in the available news feed over the past two business days. This disconnect suggests the move was either triggered by an event not yet picked up by mainstream financial feeds, or driven by technical and microstructure factors common to lower-priced stocks. EJH as a home services company with limited float and retail investor presence may be prone to sharp moves on modest volume. Possible mechanical causes include forced liquidations, portfolio rebalancing, or short-covering reversal, but without corroborating reporting these remain uninformed speculation. The absence of news makes it impossible to rule out a delayed corporate announcement, insider trading notification, or sector-wide selloff that simply has not yet been reflected in the headlines provided.

ASPCR

A SPAC III Acquisition Corp.

$0.11−$0.04

-26.7%

NASDAQ

No news headlines were available in the last 48 hours, so the 26.67% drop cannot be attributed to a disclosed catalyst. SPAC stocks often trade on liquidity, redemption dynamics, or broader sector sentiment shifts.

With zero headlines in the recent news feed, the cause of ASPCR's sharp decline remains unconfirmed by reported events. However, SPACs (Special Purpose Acquisition Companies) are structurally prone to price volatility independent of news. Common drivers include redemption pressure from shareholders ahead of merger deadlines, deteriorating deal economics or sponsor activity, or simply low trading volume amplifying small trades in thinly traded securities. At $0.11, this stock is trading near or below typical SPAC liquidation value, suggesting possible redemption cascades or a failed merger timeline. It is also possible the decline reflects a delayed market reaction to an announcement that has not yet appeared in the news feed, or technical selling pressure.

CYAN

Cyanotech CorpConsumer Defensive

$0.39−$0.14

-26.4%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours, so the 26.42% drop in CYAN cannot be directly attributed to a disclosed event. The decline likely reflects broader market conditions, technical selling, or undisclosed company developments.

The absence of recent news makes causal attribution speculative. Cyanotech is a small-cap biotech or specialty chemicals firm trading at $0.39, and stocks in this category are often sensitive to liquidity constraints, sector rotations, short-covering reversals, or delayed announcements that may not immediately surface on major news feeds. The magnitude of the drop—ranking 18th among daily losers—suggests either a material negative catalyst that has not yet been widely reported, or significant technical selling pressure on a low-priced stock with potentially thin trading volume. Without news confirmation, we cannot rule out earnings disappointment, clinical setbacks, insider selling, or simply adverse momentum in the microcap space.

NEXR

Nexera Technologies Ltd.Consumer Cyclical

$0.25−$0.08

-25.0%

BCAR

D. BORAL ARC ACQUISITION I CORPFinancial Services

$7.84−$2.54

-24.4%

NASDAQ · Mkt cap $226 M

No news headlines were found in the last 48 hours, so the 24.45% drop cannot be attributed to a specific announced event. The decline likely reflects either a broad market move, a delayed reaction to prior news, or sector-specific pressure affecting SPAC-related securities.

The absence of recent news makes it impossible to pinpoint a direct catalyst for BCAR's sharp decline. D. Boral ARC Acquisition I is a SPAC (special purpose acquisition company), a security class that typically experiences volatility around merger announcements, deal closures, or changes in redemption terms. SPACs are also sensitive to broader shifts in sentiment toward blank-check companies and can react to liquidity concerns, warrant exercise dynamics, or underlying business developments at their merger targets. Without headline evidence, the move could reflect technical selling, options expiration effects, or delayed disclosure of business news from the company's operations or its intended acquisition target.

BRUNW

Boost Run Inc. Warrant

$7.83−$2.48

-24.1%

DCOY

Decoy Therapeutics IncHealthcare

$3.73−$1.17

-23.9%

INDP

Indaptus Therapeutics, Inc.Healthcare

$2.05−$0.57

-21.8%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours, so the 21.76% drop cannot be attributed to a specific announced catalyst. The decline likely reflects either delayed market reaction to older news, technical selling, or clinical/regulatory setbacks typical of small-cap biotech stocks.

The absence of recent headlines despite a significant single-day decline is notable for a micro-cap biotech stock like Indaptus Therapeutics. There are several possible explanations within the typical behavior of this sector. First, the news may have been released more than 48 hours ago and the market may be repricing it now, a common pattern when small companies announce disappointing clinical trial results or regulatory rejections. Second, technical factors—profit-taking after a run-up, short seller activity, or index rebalancing—could explain the move independent of fundamental news. Third, biotech stocks are highly sensitive to unannounced developments such as negative pre-announcement rumors, insider transactions, or adverse safety signals that may not appear in formal news aggregators immediately. Without headline confirmation, we cannot rule out any of these categories.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.75−$0.21

-21.6%

NASDAQ

No news headlines were found in the last 48 hours. The 21.63% drop in this Series B rights security likely reflects either broader market conditions, technical selling, or a corporate event not yet captured in the headline feed.

There are no recent news headlines available to explain the sharp decline in AMPGZ. This is a Series B rights offering from Amplitech Group, a specialized security that typically moves on corporate actions, dilution events, or changes in the underlying company's prospects. Rights offerings are sensitive to shifts in market conditions and investor appetite for small-cap equity. The absence of news does not rule out a catalyst; it may reflect a delayed reporting lag, an internal corporate announcement not yet syndicated to Yahoo Finance RSS, or technical liquidation. Common drivers for rights stocks include deterioration in the parent company's equity value, changes in terms, or broader small-cap sector weakness. Without headlines or visibility into Amplitech's recent operating developments, attributing the move to a specific cause is speculative.

RECT

Rectitude Holdings LtdConsumer Cyclical

$1.13−$0.31

-21.5%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours for RECT, so the 21.53% drop cannot be directly attributed to a specific announced event. The decline likely reflects broad market conditions, technical selling, or undisclosed company developments.

The absence of any Yahoo Finance headlines in the past two days means we cannot point to earnings, guidance, regulatory action, or other concrete catalysts for the sharp 21.53% decline. For a micro-cap stock like RECT trading near $1.13, significant moves can occur from several sources: technical breakdown through support levels triggering stop-loss selling, sector-wide pressure affecting similar securities, changes in short interest or liquidity dynamics, delayed news from earlier that is now pricing in, or internal company developments not yet reflected in major news feeds. Without access to company filings, press releases, or social media activity, we cannot determine which hypothesis applies. The magnitude of the move relative to market indices suggests idiosyncratic rather than purely systematic factors, but we lack sufficient evidence to isolate the driver.

FFAI

Faraday Future Intelligent Electric Inc.Consumer Cyclical

$5.12−$1.38

-21.2%

NASDAQ · Mkt cap $12 M

FFAI fell 21.23% on a day when the company announced new robotics initiatives and capital market improvements, suggesting investors either viewed the announcements as insufficient or sold on news they expected to be stronger.

The headline from July 27 describes CEO YT Jia sharing a weekly update that includes an EAI Robotics Summer Camp, launch of an EAI-EDU nationwide replication strategy, and improvements to capital market performance. These are operational and educational announcements rather than concrete financial results, major partnerships, or vehicle production milestones that typically drive valuations for electric vehicle and robotics companies. The framing as "improvements to capital market performance" is notably vague and does not disclose specific metrics, revenues, or delivery numbers. For a company in FFAI's category—an early-stage EAI ecosystem player competing in a crowded and capital-intensive space—investors often require tangible proof of commercialization and path to profitability. An announcement focused on educational camps and replication strategies, without accompanying financial guidance or major customer wins, may have disappointed holders expecting stronger catalysts. Alternatively, the stock may have been under selling pressure on technical or market-wide factors unrelated to this news.

CPHI

China Pharma Holdings IncHealthcare

$1.29−$0.33

-21.0%

NYSE · Mkt cap $44 M

No news headlines were found in the last 48 hours, so the 21% decline cannot be directly attributed to a specific public announcement. The drop likely stems from a market event, technical breakdown, or rumor not yet reflected in major news feeds.

China Pharma Holdings is a small-cap Chinese pharmaceutical company trading on the NYSE, and no material news was published in the 48-hour window preceding this sharp 21% loss. Without identified headlines, the driver could fall into several categories: a delayed earnings miss or guidance cut that has not yet surfaced in the Yahoo Finance RSS feed, sector-wide pressure on Chinese equities, technical selling following a breakdown of support levels, or a company-specific rumor or insider transaction not yet formally announced. Small-cap stocks in the biotech and pharma space are also sensitive to FDA decisions, clinical trial setbacks, or regulatory actions in China that may not immediately propagate through major financial news sources. Without access to company filings, insider trading disclosures, or specialized pharma news wires, attribution remains speculative.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.03−$0.01

-20.5%

NASDAQ · Mkt cap $1.1 M

No news was reported in the last 48 hours, so the 20.51% drop likely reflects technical selling, broader market weakness, or undisclosed company developments in a highly volatile micro-cap stock.

The Alkaline Water Company is a micro-cap stock trading at $0.03, and no news headlines were found in the last 48 hours to explain the sharp decline. For stocks at this price level and market capitalization, moves of this magnitude are common and can be driven by several factors: (1) technical selling or short covering that creates outsized percentage swings on low volume, (2) sector-wide pressure affecting beverage or wellness stocks, (3) internal company developments not yet widely reported such as financing announcements, executive changes, or operational setbacks that may have circulated through investor networks before appearing in public news feeds, or (4) delayed reactions to older news. Without headline support, attribution remains speculative, though the absence of positive news itself in a micro-cap often signals investor concern.

VTIX

Virtuix Holdings Inc.Technology

$2.17−$0.53

-20.0%

NASDAQ · Mkt cap $55 M

Virtuix announced a major enterprise sale to Tesla's Optimus robot division on July 27, but the stock fell 20% the same day, suggesting the market either viewed the contract as underwhelming, lacked confidence in execution, or was already pricing in negative sentiment unrelated to this news.

The headlines report a genuinely positive development: Virtuix secured its first Omni One Enterprise system sale to Tesla's high-profile Optimus humanoid robot division, marking expansion beyond consumer and defense into enterprise robotics. This is the type of deal that typically supports valuations for niche simulation platforms. However, a 20% same-day decline following announced good news points to either market skepticism about deal magnitude or terms, concern about Virtuix's ability to scale or deliver, pre-existing bearish sentiment that the news failed to overcome, or possible profit-taking after a recent run-up. Without information on deal size, margin profile, or booking details, the disconnect between headline positivity and price action suggests the market's interpretation diverged sharply from what the press release framed as favorable.

AKAN

Akanda Corp.Healthcare

$6.22−$1.51

-19.5%

NASDAQ · Mkt cap $2.6 M

No news headlines were published in the last 48 hours, making it impossible to identify a specific catalyst for the 19.53% decline in AKAN stock.

Akanda Corp. experienced a sharp single-day drop of nearly 20% without any accompanying news coverage in the most recent 48-hour window. This absence of headline-level coverage does not rule out a material event; the market may be reacting to a development that has not yet been widely reported, delayed news distribution, or an earnings release or regulatory filing that occurred outside normal news channels. For a smaller-cap cannabis or specialty pharma company like Akanda, typical catalysts include earnings misses, guidance reductions, licensing or regulatory setbacks, insider selling announcements, or sector-wide margin pressure. Without access to SEC filings, company announcements, or additional news sources beyond the provided RSS feed, any attribution remains speculative.

BXBL

BOXABL, Inc.Consumer Cyclical

$3.92−$0.93

-19.0%

TGE.WT

The Generation Essentials Group

$0.13−$0.03

-18.8%

NYSE

No news headlines were found in the last 48 hours, so the 18.75% drop cannot be directly attributed to any disclosed event. The move likely reflects technical selling, market sentiment shift, or undisclosed corporate news.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance revision, regulatory action, or M&A activity. For a micro-cap stock trading at $0.13 on the NYSE, daily volatility can be high and driven by multiple factors. The move could reflect technical weakness, short covering reversal, broader sector pullback, or informal news circulation (social media, message boards) not yet captured in major financial newswires. Without structural knowledge of TGE.WT's specific characteristics—whether it is a warrant, structured product, or equity—we cannot rule out mechanics-based selling. The lack of news combined with the severity of the loss suggests either a delayed reaction to older events or momentum-driven technical selling.

SKYQ

Sky Quarry Inc.Energy

$3.83−$0.87

-18.5%

NASDAQ · Mkt cap $12 M

Sky Quarry Inc. fell 18.51% on July 27, 2026, but no news headlines were found in the last 48 hours, so the specific catalyst remains unclear and could stem from technical selling, sector headwinds, or undisclosed developments.

No recent news headlines are available to explain the sharp 18.51% decline in SKYQ. Without access to company-specific announcements, earnings releases, regulatory filings, or industry updates, pinpointing the exact cause is not possible from the provided evidence. The stock's ranking as the 33rd biggest loser suggests it was part of a broader market or sector rotation rather than an isolated move. Common catalysts for such declines in smaller-cap stocks typically include disappointing earnings or guidance revisions, operational setbacks, insider selling, analyst downgrades, or shifts in investor risk appetite. Without confirmed news, these remain speculative hypotheses rather than established facts.

ZCMD

Zhongchao IncHealthcare

$1.22−$0.27

-18.4%

NASDAQ · Mkt cap $6.2 M

No headlines were found in the last 48 hours to explain the 18.37% drop in ZCMD, so the cause remains unclear; the move could reflect technical selling, a delayed market reaction, or an untracked news event.

Yahoo Finance returned no recent news headlines for Zhongchao Inc in the 48 hours surrounding this significant 18 percent single-day decline. Without concrete news, we cannot point to a specific catalyst such as earnings, regulatory action, or guidance revision. For a low-priced NASDAQ-listed company like ZCMD, typical drivers of sharp single-day declines include sudden earnings misses or revenue shortfalls, unexpected management changes or insider selling, regulatory or compliance concerns in cross-border trading, or heavy technical liquidation if the stock had become overbought. It is also possible the stock experienced a material announcement via a filing or press release that has not yet propagated to the Yahoo Finance feed, or that the decline was driven by broader sector rotation or short-selling activity rather than a company-specific event.

MNDR

Mobile-health Network SolutionsHealthcare

$1.78−$0.40

-18.2%

NASDAQ · Mkt cap $2.0 M

MNDR announced an AI-powered digital healthcare joint venture with Jospong in Ghana on the same day it fell 18%, suggesting investor skepticism about the deal's near-term value creation or market timing concerns despite the expansion opportunity.

The only headline provided is a press release announcing a joint venture between MNDR and Jospong to build an AI-driven healthcare platform in Ghana with potential expansion into Sub-Saharan Africa. This is normally considered a positive development—a strategic partnership, emerging-market expansion, and AI positioning. However, the stock dropped 18% on the announcement day, which is counterintuitive. Possible explanations include: (1) investors viewed the Ghana focus as lower-priority or lower-revenue relative to core markets, (2) concerns about the JV structure or dilution of ownership/control, (3) the partnership announcement masked weaker underlying business trends or guidance that leaked beforehand, or (4) the market is already pricing in execution risk or unfavorable deal terms not detailed in the headline. Without access to the full press release, earnings call, or contemporaneous analyst commentary, the exact reason for the sell-off remains unclear.

FAMI

Farmmi IncConsumer Defensive

$0.15−$0.03

-18.0%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours for Farmmi Inc, so the 18% decline cannot be directly attributed to any disclosed event. The drop likely reflects either a delayed market reaction to older news, technical selling pressure, or a sector-wide move affecting agricultural commodity st…

The absence of recent news headlines means we cannot point to a specific catalyst such as earnings disappointment, guidance cut, regulatory action, or corporate event. Farmmi is a small-cap agricultural processing and food company, and stocks in this sector can experience significant daily swings due to commodity price fluctuations, currency effects on import/export businesses, or shifts in market sentiment toward food security plays. Without access to news, the decline could reflect a reversal of earlier momentum, forced selling by retail investors, or a delayed negative disclosure not yet picked up by major news feeds. Alternatively, the move may be entirely technical rather than fundamental.

AMSS

AMASS Brands Inc.Consumer Defensive

$0.87−$0.19

-18.0%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 18% decline cannot be directly attributed to a specific announced catalyst. The drop likely reflects market dynamics, technical selling, or unmonitored news outside the provided sources.

With no recent news available to explain the move, we cannot point to a concrete catalyst such as earnings, guidance, regulatory action, or corporate announcements. AMASS Brands is a small-cap stock trading at $0.87, which makes it susceptible to several generic categories of pressure: technical breakdown or momentum reversal, sentiment shifts among retail or institutional holders, sector-wide weakness, or news disseminated through channels not captured in the Yahoo Finance RSS feed within the stated window. Without access to the company's Twitter, press releases, or other real-time information, and given the absence of traditional financial news coverage, we cannot confidently narrow the cause beyond noting that micro-cap stocks often experience sharp moves on modest volume and sentiment shifts.

OTLK

Outlook Therapeutics IncHealthcare

$1.07−$0.25

-17.9%

NASDAQ · Mkt cap $167 M

Outlook Therapeutics received FDA approval for Lytenava (wet AMD therapy) on July 27, triggering an 8.9% pre-market rally and analyst upgrades, yet the stock closed down 17.86%, suggesting a sharp reversal likely driven by profit-taking, valuation concerns, or unrelated broader market weakness.

The headlines establish that Outlook received FDA approval for its bevacizumab ophthalmic formulation, a significant regulatory win in the $8.5B US retina market. BTIG upgraded the stock to Buy the same day, and pre-market trading showed approximately 8.9% gains. However, the stock finished down 17.86%, indicating a substantial intraday reversal. This pattern suggests initial enthusiasm was followed by either significant profit-taking after the pre-market spike, market participants reassessing the commercial opportunity or peak pricing relative to long-term value, or broader sector headwinds unrelated to Outlook itself. The headlines do not disclose any negative clinical data, competitive threats, or guidance cuts that would directly justify the close-of-day decline, so the reversal likely reflects investor positioning and valuation recalibration rather than new adverse fundamentals.

FEMY

Femasys Inc.Healthcare

$3.06−$0.64

-17.3%

NASDAQ · Mkt cap $22 M

Femasys Inc. (FEMY) dropped 17.30% on July 27, 2026, with no news headlines available in the prior 48 hours to explain the decline, suggesting either delayed reporting of an announcement or a market-driven sell-off.

No recent news headlines were found in the last 48 hours to account for this significant single-day loss. For a small-cap medical device or biotech company like Femasys, sharp unattributed drops typically stem from one of several catalyst categories: delayed disclosure of clinical trial results or regulatory setbacks, unexpected insider selling or secondary offerings, analyst downgrades not yet reflected in headline feeds, short-covering reversals or broader sector rotation out of low-liquidity names, or technical capitulation on support breaks. Without access to company filings, after-hours announcements, or real-time news feeds beyond the RSS snapshot provided, the specific trigger remains unknown. The magnitude of the move (down 17%) and its ranking as the 39th biggest loser suggests sector-wide or company-specific pressure rather than pure noise.

FEBO

Fenbo Holdings LimitedTechnology

$0.75−$0.15

-16.9%

NASDAQ · Mkt cap $8.6 M

No news headlines were found in the last 48 hours, so the 16.88% drop cannot be attributed to a specific announced event. The decline likely stems from technical selling, market sentiment, or untracked developments.

Fenbo Holdings Limited experienced a significant single-day loss with no identifiable headline catalyst in the Yahoo Finance RSS feed during the relevant window. For a micro-cap stock trading at $0.75, price movements of this magnitude typically reflect thin liquidity and high volatility rather than fundamental news. Possible explanations include technical breakdown below a support level, profit-taking after a prior run, short-seller activity, or a delayed market reaction to company filings or press releases not captured in the headline feed. Micro-cap stocks are also prone to momentum-driven selling with minimal information flow. Without access to SEC filings, company press releases, or broader financial media coverage from the snapshot date, pinpointing the precise catalyst is not possible.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.09−$0.02

-16.7%

NASDAQ · Mkt cap $4.8 M

No news headlines were found in the last 48 hours, so the 16.71% drop cannot be directly attributed to a specific announced event. The decline likely stems from technical selling, broader market conditions, or an unannounced development not yet captured by major news feeds.

The absence of recent news makes it impossible to pinpoint a concrete catalyst for RITR's sharp 16.71% decline to $0.09. For a micro-cap stock trading at this price level, typical drivers of single-day losses include heavy institutional liquidation or index rebalancing, short-seller activity targeting low-float securities, deterioration in sector-wide sentiment affecting logistics or tech holdings, or delayed disclosure of operational challenges that may not yet have reached mainstream news aggregators. Penny stocks and very low-priced securities are also prone to high volatility on thin trading volume. Without corroborating headlines, market depth data, or insider trading filings, we cannot determine whether this was demand-side weakness or a supply-side event.

UGRO

URBAN-GRO INC.Industrials

$1.36−$0.27

-16.6%

NASDAQ · Mkt cap $2.3 M

No news headlines appeared in the last 48 hours, so the 16.56% drop cannot be directly attributed to a reported event; the decline may reflect technical selling, sector weakness, or market-moving information not yet captured in RSS feeds.

Urban-Gro Inc. dropped 16.56% on July 27, 2026, but no financial news, earnings releases, regulatory announcements, or other disclosed events appear in the available 48-hour news window. This disconnect suggests either that the catalyst occurred before the snapshot window, arrived through channels not reflected in Yahoo Finance RSS, or was driven by technical factors such as short covering, options expiration effects, or broad market moves in the horticulture technology or cleantech sectors. Small-cap stocks trading near $1.36 can experience outsized moves on low volume or sentiment shifts without corresponding headlines. Without confirmed news, the cause remains speculative.

LTCH

Latch, Inc.Technology

$0.15−$0.03

-16.3%

NASDAQ · Mkt cap $31 M

No headlines were found in the last 48 hours, so the 16.29% drop cannot be directly attributed to any announced news. The decline likely reflects either technical selling pressure, broader market sentiment, or undisclosed developments not yet captured in major news feeds.

The absence of any Yahoo Finance headlines in the last 48 hours means the move cannot be tied to an earnings report, guidance revision, clinical update, or other major corporate announcement that would normally drive a single-day 16% decline. For a micro-cap stock like Latch trading at $0.15, typical catalysts include liquidity events, insider activity, short-seller reports, technical breakdowns of support levels, or sector-wide contagion. Without headline evidence, the most likely explanations fall into two buckets: (1) a technical breakdown where the stock lost key support and triggered algorithmic or margin-related selling, or (2) a delayed or off-wire catalyst such as a conference call outcome, SEC filing, or social-media-driven sentiment shift that hasn't yet reached mainstream financial news. Latch operates in smart access control, a lower-volume, speculative sector where single-day swings of this magnitude are not uncommon even on modest volume.

MOBQ

Mobiquity Technologies, Inc.Communication Services

$0.71−$0.14

-16.2%

NASDAQ · Mkt cap $19 M

Mobiquity Technologies fell 16.18% on July 27, 2026, but no news headlines from the last 48 hours are available to explain the decline, making the specific catalyst unclear.

The absence of any Yahoo Finance news in the 48-hour window preceding this significant 16% single-day drop makes it impossible to attribute the move to a specific corporate event such as earnings, guidance revision, product announcement, or regulatory action. For a micro-cap stock like Mobiquity trading at $0.71, price declines of this magnitude are often driven by one of several categories: technical selling or short-covering reversals, a delayed or unindexed news announcement that reached market participants before wider distribution, insider trading disclosures, or simply the ordinary volatility characteristic of low-priced equities with lower liquidity. It is also possible the decline occurred on low volume or was driven by sector-wide headwinds in technology or telecom infrastructure, Mobiquity's primary business domain. Without headline evidence or real-time volume and order flow data, the proximate cause remains unconfirmed.

NIXX

Nixxy, Inc.Communication Services

$0.70−$0.13

-16.0%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 16% decline in NIXX cannot be attributed to a specific announced catalyst; the drop likely reflects technical selling, sector weakness, or undisclosed company-specific developments.

The absence of any headlines in the Yahoo Finance RSS feed over the past two days means we cannot identify a concrete news-driven reason for the 16% drop. NIXX trades at a very low price point of $0.70 and ranks as the 45th biggest loser of the day, suggesting broad selling pressure. Stocks in this price range and category are typically subject to higher volatility and can be sensitive to multiple factors: technical breakdown below a key support level, broader sector rotation out of small-cap or speculative names, liquidity concerns, or delayed announcements that haven't yet propagated to mainstream financial news feeds. Without headline confirmation, we are limited to naming categories of likely causes rather than identifying a specific event. The stock's low valuation also means it may be more prone to momentum-driven or sentiment-driven moves that precede formal news disclosure.

ADVB

Advanced Biomed Inc. Common StockHealthcare

$14.48−$2.70

-15.8%

NASDAQ · Mkt cap $14 M

No news headlines were published in the last 48 hours for ADVB, so the 15.85% drop cannot be directly attributed to a known catalyst. The decline likely stems from sector weakness, technical selling, or undisclosed developments.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to pinpoint a specific news catalyst for ADVB's sharp 15.85% decline. Advanced Biomed is a small-cap biomedical company, and stocks in this category are typically sensitive to clinical trial results, regulatory decisions, capital raises, partnership announcements, or broader biotech sector sentiment shifts. Given the magnitude of the drop and the lack of disclosed news, the move could reflect delayed market reaction to an announcement made just outside the 48-hour window, a technical breakdown from prior resistance levels, sector-wide weakness in biomedical stocks, or rumors and speculation not yet reflected in major news feeds. Without headline evidence or structural detail about the company's capital structure or market dynamics, the true cause remains unclear.

UAC.WT

$0.87−$0.16

-15.5%

TMDE

TMD Energy LimitedEnergy

$0.81−$0.15

-15.5%

NYSE · Mkt cap $18 M

No news headlines were published in the last 48 hours about TMDE, so the 15.47% drop cannot be directly attributed to a reported event. The decline likely reflects sector weakness, technical selling, or untracked negative developments.

The absence of any headlines in the Yahoo Finance RSS feed over the past two days means we cannot point to a specific corporate announcement, earnings release, regulatory action, or strategic decision as the cause of this substantial single-day loss. For a micro-cap or thinly-traded energy stock like TMDE, declines of this magnitude can occur due to several factors that often go unreported or are reported through channels outside mainstream financial news feeds: sector-wide selloff in energy equities, technical breakdown below key support levels, insider selling, margin calls in the broader market, or delayed negative news that has not yet been picked up by major outlets. Without access to real-time volume data, insider filings, or company-specific announcements from non-RSS sources, the exact catalyst remains unclear.

AIEV

Thunder Power Holdings, Inc.Consumer Cyclical

$0.11−$0.02

-15.3%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours to explain Thunder Power Holdings' 15.35% drop on July 27, 2026, so the decline likely stems from technical selling, market conditions affecting micro-cap stocks, or an untracked announcement.

The absence of any reported news in the 48-hour window makes it difficult to pin down a specific catalyst for this stock's significant decline. Thunder Power Holdings trades on NASDAQ at a very low price point ($0.11) and ranks as the 49th biggest loser of the day, suggesting broad selling pressure rather than a single idiosyncratic event. For micro-cap stocks like this, declines often reflect technical factors such as stop-loss cascades, liquidity concerns, or a shift in retail investor sentiment. It is also possible that a material announcement was made but not yet indexed by the RSS feed used, or the market reacted to broader sector headwinds or macro conditions. Without specific news evidence, the true driver remains uncertain.

IPW

iPower Inc.Consumer Cyclical

$0.65−$0.10

-14.8%

NASDAQ · Mkt cap $5.9 M

No news headlines were found in the last 48 hours, so the 14.83% drop on IPW likely stems from technical selling, a delayed announcement not yet indexed in major feeds, or sector-wide pressure in hydroponic/cannabis equipment stocks.

The absence of recent news makes pinpointing a specific catalyst difficult. iPower Inc. operates in the hydroponic and indoor farming equipment space, a sector sensitive to regulatory changes, cannabis legalization shifts, and margin pressures from larger competitors. A sharp single-day drop without identifiable headline news could reflect several plausible causes: (1) a delayed earnings miss or guidance cut released outside standard times, (2) sector rotation or broader small-cap liquidation, (3) a technical breakdown below key support levels triggering algorithmic selling, or (4) a rumor or social-media-driven sentiment shift not yet reflected in major news wires. Without concrete evidence, we cannot distinguish between these scenarios with confidence.